Low levels of insulin or IGF-1 and insulin resistance cause the inhibition of Akt phosphorylation and subsequent reductions in phosphorylated GSK3β, resulting in the degradation of β-catenin proteins. This evidence concerns the gene AKT1 and Insulin resistance.